Header Logo

Connection

CHARLES MINARD to Medulloblastoma

Back to Details
This is a "connection" page, showing publications CHARLES MINARD has written about Medulloblastoma.
CHARLES MINARD
Connection Strength
0.164
Medulloblastoma
  1. Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma. Cancer. 2023 07 15; 129(14):2245-2255.
    View in: PubMed
    Score: 0.164
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.